SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-014586
Filing Date
2024-02-13
Accepted
2024-02-13 16:16:33
Documents
1
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 5 ownership.html 5  
1 5 ownership.xml 5 3035
  Complete submission text file 0000950170-24-014586.txt   4781
Mailing Address 450 LEXINGTON AVENUE, FLOOR 13 NEW YORK NY 10017
Business Address
Sulzberger Gabrielle (Reporting) CIK: 0001262388 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-39311 | Film No.: 24626161

Mailing Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141
Business Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Issuer) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)